109 related articles for article (PubMed ID: 19221477)
1. Chromosome 1q gain is not associated with a poor outcome in childhood medulloblastoma: requirements for the validation of potential prognostic biomarkers.
Clifford SC; O'Toole K; Ellison DW
Cell Cycle; 2009 Mar; 8(5):787. PubMed ID: 19221477
[No Abstract] [Full Text] [Related]
2. Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma.
McCabe MG; Bäcklund LM; Leong HS; Ichimura K; Collins VP
Neuro Oncol; 2011 Apr; 13(4):376-83. PubMed ID: 21292688
[TBL] [Abstract][Full Text] [Related]
3. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.
Pfister S; Remke M; Benner A; Mendrzyk F; Toedt G; Felsberg J; Wittmann A; Devens F; Gerber NU; Joos S; Kulozik A; Reifenberger G; Rutkowski S; Wiestler OD; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
J Clin Oncol; 2009 Apr; 27(10):1627-36. PubMed ID: 19255330
[TBL] [Abstract][Full Text] [Related]
4. Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma.
Lo KC; Ma C; Bundy BN; Pomeroy SL; Eberhart CG; Cowell JK
Clin Cancer Res; 2007 Dec; 13(23):7022-8. PubMed ID: 18056178
[TBL] [Abstract][Full Text] [Related]
5. Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement.
Bien-Willner GA; López-Terrada D; Bhattacharjee MB; Patel KU; Stankiewicz P; Lupski JR; Pfeifer JD; Perry A
Neuro Oncol; 2012 Jul; 14(7):831-40. PubMed ID: 22573308
[TBL] [Abstract][Full Text] [Related]
6. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system.
Schofield DE; Yunis EJ; Geyer JR; Albright AL; Berger MS; Taylor SR
Cancer; 1992 Mar; 69(5):1307-14. PubMed ID: 1739930
[TBL] [Abstract][Full Text] [Related]
7. A case of cerebellar medulloblastoma with a single chromosome abnormality.
Stratton MR; Darling J; Cooper CS; Reeves BR
Cancer Genet Cytogenet; 1991 May; 53(1):101-3. PubMed ID: 2036631
[TBL] [Abstract][Full Text] [Related]
8. Biologic risk stratification of medulloblastoma: the real time is now.
Fisher PG; Burger PC; Eberhart CG
J Clin Oncol; 2004 Mar; 22(6):971-4. PubMed ID: 14970187
[No Abstract] [Full Text] [Related]
9. FISH and chips: the recipe for improved prognostication and outcomes for children with medulloblastoma.
Ramaswamy V; Northcott PA; Taylor MD
Cancer Genet; 2011 Nov; 204(11):577-88. PubMed ID: 22200083
[TBL] [Abstract][Full Text] [Related]
10. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.
Pfaff E; Remke M; Sturm D; Benner A; Witt H; Milde T; von Bueren AO; Wittmann A; Schöttler A; Jorch N; Graf N; Kulozik AE; Witt O; Scheurlen W; von Deimling A; Rutkowski S; Taylor MD; Tabori U; Lichter P; Korshunov A; Pfister SM
J Clin Oncol; 2010 Dec; 28(35):5188-96. PubMed ID: 21060032
[TBL] [Abstract][Full Text] [Related]
11. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in medulloblastoma, including DNA ploidy.
Zerbini C; Gelber RD; Weinberg D; Sallan SE; Barnes P; Kupsky W; Scott RM; Tarbell NJ
J Clin Oncol; 1993 Apr; 11(4):616-22. PubMed ID: 8478656
[TBL] [Abstract][Full Text] [Related]
13. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
[TBL] [Abstract][Full Text] [Related]
14. Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis.
Rutkowski S; von Hoff K; Emser A; Zwiener I; Pietsch T; Figarella-Branger D; Giangaspero F; Ellison DW; Garre ML; Biassoni V; Grundy RG; Finlay JL; Dhall G; Raquin MA; Grill J
J Clin Oncol; 2010 Nov; 28(33):4961-8. PubMed ID: 20940197
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 9q and 16q loss identified by genome-wide pooled-analysis are associated with tumor aggressiveness in patients with classic medulloblastoma.
Coco S; Valdora F; Bonassi S; Scaruffi P; Stigliani S; Oberthuer A; Berthold F; Andolfo I; Servidei T; Riccardi R; Basso E; Iolascon A; Tonini GP
OMICS; 2011 May; 15(5):273-80. PubMed ID: 21348762
[TBL] [Abstract][Full Text] [Related]
16. C-MYC expression in medulloblastoma and its prognostic value.
Herms J; Neidt I; Lüscher B; Sommer A; Schürmann P; Schröder T; Bergmann M; Wilken B; Probst-Cousin S; Hernáiz-Driever P; Behnke J; Hanefeld F; Pietsch T; Kretzschmar HA
Int J Cancer; 2000 Sep; 89(5):395-402. PubMed ID: 11008200
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of medulloblastoma in children under age of three years.
Ryzhova MV; Zheludkova OG; Kumirova ÉV; Shishkina LV; Panina TN; Gorelyshev SK; Khukhlaeva EA; Mazerkina NA; Matuev KB; Medvedeva OA; Tarasova EM; Kholodov BV; Kapitul'skaia OIu
Zh Vopr Neirokhir Im N N Burdenko; 2013; 77(1):3-10; discussion 11. PubMed ID: 23659115
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor genes and medulloblastoma.
Cogen PH; McDonald JD
J Neurooncol; 1996 Jul; 29(1):103-12. PubMed ID: 8817421
[TBL] [Abstract][Full Text] [Related]
19. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
[TBL] [Abstract][Full Text] [Related]
20. Ploidy and proliferative index in medulloblastoma: useful prognostic factors?
Tait DM; Eeles RA; Carter R; Ashley S; Ormerod MG
Eur J Cancer; 1993; 29A(10):1383-7. PubMed ID: 8398263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]